CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 40 filers reported holding CTI BIOPHARMA CORP in Q3 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,708 | -21.5% | 1,121 | +9.8% | 0.00% | – |
| Q4 2022 | $6,000 | – | 1,021 | +4761.9% | 0.00% | – |
| Q3 2022 | $0 | – | 21 | -4.5% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 22 | -99.8% | 0.00% | – |
| Q1 2022 | $50,000 | +92.3% | 10,649 | 0.0% | 0.00% | – |
| Q4 2021 | $26,000 | -18.8% | 10,649 | -4.5% | 0.00% | – |
| Q3 2021 | $32,000 | +18.5% | 11,149 | +4.4% | 0.00% | – |
| Q2 2021 | $27,000 | -12.9% | 10,681 | 0.0% | 0.00% | – |
| Q1 2021 | $31,000 | +1450.0% | 10,681 | +1230.1% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 803 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 803 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 803 | -29.7% | 0.00% | – |
| Q1 2020 | $1,000 | – | 1,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,068,191 | $4,719,000 | 9.14% |
| CAXTON CORP | 619,460 | $719,000 | 0.76% |
| BVF INC/IL | 6,929,690 | $8,038,000 | 0.50% |
| NEA Management Company, LLC | 7,140,450 | $8,283,000 | 0.33% |
| Orbimed Advisors | 9,520,600 | $11,044,000 | 0.16% |
| Renaissance Technologies | 2,103,792 | $2,440,000 | 0.00% |
| Paloma Partners Management Co | 30,289 | $35,000 | 0.00% |
| WEDBUSH SECURITIES INC | 12,600 | $15,000 | 0.00% |
| HRT FINANCIAL LP | 19,710 | $22,000 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 33 | $0 | 0.00% |